Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
| Autor: | Viale, G. *, Regan, M.M., Dell'Orto, P., Mastropasqua, M.G., Maiorano, E., Rasmussen, B.B., MacGrogan, G., Forbes, J.F., Paridaens, R.J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R.D., Price, K.N., Goldhirsch, A., Gusterson, B.A., Coates, A.S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2011 22(10):2201-2207 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|